Altria Reports Q1 2023 Earnings, Decline in Revenue.

Apr.27.2023
Altria Reports Q1 2023 Earnings, Decline in Revenue.
Altria Q1 2023 results show declining revenue, but strong performance in smokeless products and a call for stronger tobacco regulation.

Altria has released its Q1 2023 results at 9am EST on April 27th (9pm Beijing time). The earnings, audited under GAAP, show a 2.9% YoY drop in net revenue to $5.719 billion, and a 1.2% YoY drop in revenue after consumer taxes to $4.763 billion. The reported tax rate is 27.9%, up 1.2 points from the same period last year, while the adjusted tax rate is 25.0%, down 0.1 points from last year. Adjusted earnings per share were $1.18, a 5.4% YoY growth, while reported earnings per share were $1, a 7.4% YoY drop.


Altria CEO Billy Gifford announced a solid start to the business, with the tobacco division performing exceptionally well despite the challenging macroeconomic environment, achieving a strong adjusted earnings per share growth of 5.4%.


Altria, a major tobacco company, has reported impressive growth in shipment volume and market share for its smokeless products, specifically its brand on! In the first quarter of 2023, Altria's smokeless products had a total shipment volume of 190 million boxes, with on! accounting for 25.2 million of those boxes, an increase of 37.7% from the previous year. Its market share has also increased each quarter, reaching 6.5%.


Smoking-in-mouth shipments increase | Source: Altria


In addition, other smokeless tobacco products such as Copenhagen, Skoal, and others have also seen an increase as shown in the graph below.


Source: Altria


A call for tobacco law enforcement in 2022: California officially banned flavored (including menthol) tobacco and e-cigarette products through a ballot initiative. Altria has stated that it is actively complying with the new policy, ceasing the transportation of related products to California. This has resulted in a 12.8% decline in shipments by its subsidiary, PM USA, to California, as shown in the following graph.


California flavor ban results in reduced shipments | Source: Altria


In its latest financial report, Altria mentioned that despite the bans on flavored tobacco and menthol in California, flavored tobacco products are still being sold at the retail level. Altria is calling for increased enforcement. Gifford stated that "40% of smokers in California are still using menthol cigarettes," and many menthol and flavored tobacco products have been renamed to avoid regulation.


PowerPoint title: Poor Law Enforcement in California | Source: Altria


According to financial reports, Altria's net income from traditional combustible cigarettes has decreased by 3.3% compared to the previous year. This is primarily due to a decrease in shipment volume and an increase in promotional investments, as shown in the graph below.


Cigarette revenue decline | Source: Altria


Altria released its full-year performance guidance for 2023 in its financial report. The company reiterated its commitment to delivering adjusted earnings per share in the range of $4.98 to $5.13 in 2023, representing a 3% to 6% increase from 2022. Altria stated that the guidance takes into account various scenarios, given the uncertainties in the external environment, including factors such as high inflation, rising interest rates, global supply chain disruptions, as well as regulatory and legislative developments. The company will continue to monitor economic and policy factors closely.


Financial Outlook for 2023 | Source: Altria


The company's full-year adjusted earnings per share guidance for 2023 includes planned investments to support its vision, such as ongoing research, development and regulatory preparation costs for smokeless products, strengthening our digital consumer engagement systems, and supporting market activities for smokeless products. The guidance range also includes expected lower net periodic benefit income due to market factors (including higher interest rates) and the impact of liquidating the former financial services business in 2022. The guidance range does not include the potential financial impact of the NJOY transaction.


Altria has announced its corporate goals for 2028 in its latest performance report. The company plans to achieve these goals through various measures, including achieving mid-single-digit adjusted earnings per share growth by 2028, setting a progressive dividend target with mid-single-digit dividend growth, maintaining a debt/EBITDA ratio of approximately 2.0, maintaining its leadership position in the US tobacco market, and sustaining a total adjusted after-tax profit margin of at least 60% annually for the next five years.


Additionally, Altria plans to achieve growth targets in its portfolio of smokeless products in the United States, including a sales volume increase of at least 35% by 2022, and increasing the net revenue of smokeless products from $2.6 billion in 2022 to $5 billion, with $2 billion coming from innovative smokeless products. The company also aims to expand its international competitiveness in innovative smokeless and non-nicotine products for long-term growth, and anticipates developing strategies for these growth areas in the next 12 months.


Confidence in the electronic vaporization field is strong. This is due in part to Altria's recent announcement of its acquisition of NJOY, a leading electronic vaporization company in North America. While the company's financial report did not include specific data on this acquisition, the CEO stated that he is optimistic about NJOY's future under the Altria umbrella. He explained that NJOY is the only pod vape product to have applied for pre-market tobacco product application (PMTA) with the FDA.


Altria is in the process of acquiring NJOY.


2FIRSTS will continue to track and report on the latest developments from Altria Corporation. Stay tuned.


Related reading:


California bans flavored condiments.


In the US electronic cigarette market, Vuse has increased its market share by 31.1%, whereas NJoy has experienced a decline of 10.9%.


Altria and Reynolds spend large amounts of lobbying funds to "stir up" black groups against the mint-flavored cigarette ban.


References:


Altria's Q1 financial report


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
A 21-year-old man in Singapore is assisting with investigations after a video allegedly showing him vaping inside a bus went viral on social media. The Health Sciences Authority (HSA) said via its Instagram Stories that it had identified the man and seized e-vaporisers and 12 pods from his home on Feb 3. Vape-related penalties were strengthened from Sept 1, with first-time adult users liable to a $700 fine, and third-time offenders prosecuted and fined up to $2,000.
Feb.06
UK reminds vaping firms to apply for new excise duty registration from April 2026
UK reminds vaping firms to apply for new excise duty registration from April 2026
HMRC has issued a reminder urging vaping manufacturers, importers and warehouse operators to prepare for registration under the UK’s new Vaping Products Duty, with applications opening in April 2026 and the duty taking effect in October.
Feb.10
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan Named 2026 SRNT Fellow for Contributions to Nicotine Research
Andy Tan, Ph.D., has been named a 2026 Fellow of the Society for Research on Nicotine and Tobacco (SRNT), an international professional association dedicated to advancing nicotine and tobacco research. Fellows are selected for outstanding research contributions as well as leadership, mentoring, and policy engagement within the field.
Feb.23
UK’s North Yorkshire Council plans up to £477,000 spend on e-cigarettes to support quitting smoking
UK’s North Yorkshire Council plans up to £477,000 spend on e-cigarettes to support quitting smoking
North Yorkshire Council in the UK is set to spend up to £477,000 on e-cigarettes to support residents quitting smoking. Since e-cigarettes were added to the council’s Living Well Smokefree service in July 2023, 487 people have used them to quit, with about a third remaining smoke-free after a year.
Mar.03 by 2FIRSTS.ai
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
PMTA Manufacturing Panel Sees Small Firms Warn “Unknown Is Death” as FDA Defends Review Boundaries
During FDA’s Feb 10 PMTA roundtable (manufacturing controls panel), small ENDS manufacturers warned that uncertainty in manufacturing expectations creates existential financial risk. FDA officials reiterated review flexibility is constrained by statutory and scientific boundaries. The panel debated testing standards, documentation requirements, open-system responsibility, supply chain changes, and software updates—highlighting unresolved PMTA challenges for small manufacturers.
Feb.11
Thailand’s National Health Commission Office Reviews Two Years of E-Cigarette Control Efforts and Plans Further Recommendations
Thailand’s National Health Commission Office Reviews Two Years of E-Cigarette Control Efforts and Plans Further Recommendations
Thailand’s National Health Commission Office and partner agencies held a public policy forum on March 13 to review results from the past two years of efforts to protect children and youth from e-cigarettes and to prepare recommendations for submission to the National Health Commission.
Mar.17 by 2FIRSTS.ai